HTA and market access

Showing 9 of 0 results

• Transporting comparative effectiveness evidence between countries: considerations for health technology assessment

  Pharmacoeconomics

  • Real-world evidence
  • Video
  • Publication summary
  • Publications
  • HTA and market access
• Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort study

  BMJ Open

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • HTA and market access
• Transportability of overall survival estimates from US to UK populations receiving first-line treatment for advanced non-small-cell lung cancer

  ISPOR EU

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • HTA and market access
• Data quality 2.0: The future of real-world evidence
  • Real-world evidence
  • Article
  • Methodology
  • HTA and market access
• How we think about carrying evidence across country borders
  • Real-world evidence
  • Article
  • HTA and market access
• Exploring the potential for RWD to reduce uncertainty in HTA decision-making: a case study of long-term survival outcomes

  Value in Health

  • Real-world evidence
  • Publication summary
  • Publications
  • Non-small cell lung cancer
  • HTA and market access
• Exploring the potential for EHR-derived real-world data to reduce uncertainty in HTA decision-making: a case study of long-term survival outcomes

  EU ISPOR

  • Publications
  • Comparative effectiveness
  • Non-small cell lung cancer
  • HTA and market access
• Approaches for enhanced extrapolation of long-term survival outcomes using RWD

  Value in Health

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • Comparative effectiveness
  • Metastatic breast cancer
  • HTA and market access
• Temporal considerations for Health Technology Assessments that use real-world data
  • Real-world evidence
  • Article
  • HTA and market access